Skip to content

36 Versus 42 Hour Time Interval From Ovulation to Intrauterine Insemination

36 Versus 42 Hour Time Interval From Ovulation Induction to Intrauterine Insemination in Stimulated Cycles With GnRH Antagonists

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02210611
Enrollment
71
Registered
2014-08-07
Start date
2015-01-31
Completion date
2018-04-29
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

The purpose of this study is to prove that a higher clinical pregnancy rate can be achieved with a 42 to 44 hour time interval between ovulation trigger and intrauterine insemination than a 36 to 38 hour time interval in stimulated cycles utilizing gonadotropins and GnRH antagonists.

Interventions

PROCEDUREIntrauterine Insemination 36 hours

Intrauterine insemination 36 hours after ovulation induction

PROCEDUREIntrauterine Insemination 42 hours

Intrauterine insemination 42 hours after ovulation induction

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
17 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who can be monitored for follicle growth and hormone measurements on the day of ovulation trigger, or one day before. 2. Patients who have no more than 4 follicles of 14 mm or more 3. Patients who have no more than 6 follicles of 10 mm or more

Exclusion criteria

1. Patients who cannot give informed consent to language or comprehension barriers 2. Patients who are deemed to be at high risk for high order multiple gestations 3. Patients who cannot be monitored on the day of hCG administration or one day before

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate4 weeks following insemination

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026